US-based medical devices developer Elixir Medical has announced that the results of its CE Mark-approved DESyne BD Novolimus Eluting Coronary Stent System with biodegradable polymer coating were outstanding. Its CE Mark-approved DESyne BD ...
Global healthcare company Novo Nordisk has announced plans to launch its obesity treatment drug, liraglutide, in the US by the end of 2014. Novo chief scientific officer Mads Thomsen was quoted by health24.com as saying that liraglutide ...
Tags: Obesity Drug, Medicine
Pharmaceutical company Parion Sciences and product development firm Cambridge Consultants have developed a new surfing-inspired aerosol delivery system that can help people suffering with cystic fibrosis to get the benefits of saltwater ...
St. Jude Medical, a medical device firm, has announced that its EnligHTN Multi-Electrode Renal Denervation System offers a safe, rapid and sustained reduction in measurements of blood pressure after a year. The company presented the new ...
Tags: EnligHTN Renal, Blood Pressure
Medtronic has completed randomizing Symplicity HTN-3, a clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure that decreases the ...
Tags: Medtronic, Randomizing Symplicity
Celgene International has obtained FDA priority review status for Abraxane (paclitaxel protein-bound particles for injectable suspension) supplemental new drug application (sNDA). The application covers the use of Abraxane and gemcitabine ...
Tags: Celgene sNDA, FDA Priority
Global clinical packaging services provider Bellwyck Packaging Solutions has moved its US Clinical Services division to a new facility located at 8946 Global Way, West Chester, Ohio. The new facility will house all US clinical services ...
Tags: Bellwyck Packaging, Packaging
Asthma Intervention Research 2 (AIR2) clinical trial data has demonstrated that the Boston Scientific Alair Bronchial Thermoplasty (BT) System continues to show therapy benefits in adult patients with severe uncontrolled asthma. BT ...
BioRestorative Therapies (BRT) has signed a consulting agreement with Dexterity, to develop and manufacture BRT's proprietary therapeutic delivery device for its intervertebral disc stem cell therapy program, brtxDISC (Disc Implanted Stem ...
Canada-based pharmaceutical company Nuvo Research has received US Patent relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis and atopic dermatitis. ...
Tags: Nuvo Research, Drug Candidate
Medtronic's study has demonstrated that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of ...
Tags: CRT Device, Heart Failure Symptoms
The US Food and Drug Administration (FDA) has warned the people that the anti-seizure drug, Potiga, developed by Valeant Pharmaceuticals and co-marketed with GlaxoSmithKline, may cause eye and skin problems. FDA warned that Potiga may ...
Tags: Anti-Seizure Drug Potiga, Medicine
Global property and casualty insurer ACE Group has launched new ACE Express Private and ACE Express Not-For-Profit health care protection polices to provide comprehensive management liability coverage for health care organizations. ...
Kerecis, a medical device company focused on the treatment of tissue damage with Omega3-based regenerative technologies, has announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 ...
Tags: Kerecis, Immunology Study
GE Healthcare has entered into research collaboration agreement with Eisai for use of GE Healthcare investigational PET amyloid imaging agent, flutemetamol, to select patients for a phase I clinical trial being conducted by Eisai. The ...